过去一年中添加的文章，按日期排序
[HTML][HTML] … medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life study
JN Young, H Verma, N El Kashlan… - JAAD Case …, 2024 - jaadcasereports.org
243 天前 - … Notably, 6 of 7 patients are alive and without cancer … this pathway, including
ustekinumab and risankizumab, are … or in remission from a cancer perspective. Further studies are …
ustekinumab and risankizumab, are … or in remission from a cancer perspective. Further studies are …